{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:49:34Z","timestamp":1791179374350,"version":"4.1.0"},"reference-count":50,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T00:00:00Z","timestamp":1224547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Carcinogenesis"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cyclin D1b is an alternative transcript of the cyclin D1 gene (<jats:italic>CCND1<\/jats:italic>) expressed in human tumors. Its abundance is regulated by a single base pair polymorphism at the exon 4\/intron 4 boundary (nucleotide 870). Epidemiological studies have shown a correlation between the presence of the G870A allele (that favors the splicing for cyclin D1b) with increased risk and less favorable outcome in several forms of cancer. More recently, it has been shown that, unlike cyclin D1a, the alternative transcript D1b by itself has the capacity to transform fibroblasts in vitro. In order to study the oncogenic potential of cyclin D1b, we developed transgenic mice expressing human cyclin D1b under the control of the bovine K5 promoter (K5D1b mice). Seven founders were obtained and none of them presented any significant phenotype or developed spontaneous tumors. Interestingly, K5D1b mice do not develop the fatal thymic hyperplasia, which is characteristic of the cyclin D1a transgenic mice (K5D1a). Susceptibility to skin carcinogenesis was tested in K5D1b mice using two\u2010stage carcinogenesis protocols. In two independent experiments, K5D1b mice developed higher papilloma multiplicity as compared with wild\u2010type littermates. However, when K5D1b mice were crossed with cyclin D1KO mice, the expression of cyclin D1b was unable to rescue the carcinogenesis\u2010resistant phenotype of the cyclin D1 KO mice. To further explore the role of cyclin D1b in mouse models of carcinogenesis we carried out in silico analysis and in vitro experiments to evaluate the existence of a mouse homologous of the human cyclin D1b transcript. We were unable to find any evidence of an alternatively spliced transcript in mouse <jats:italic>Ccnd1<\/jats:italic>. These results show that human cyclin D1b has different biological functions than cyclin D1a and confirm its oncogenic properties. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/mc.20489","type":"journal-article","created":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T18:53:20Z","timestamp":1224615200000},"page":"508-516","source":"Crossref","is-referenced-by-count":13,"title":["Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (<i>CCND1b<\/i>)"],"prefix":"10.1002","volume":"48","author":[{"given":"Paola","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Benavides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Blando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian M.","family":"Senderowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo L.","family":"Rodriguez\u2010Puebla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio J.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,21]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1101\/SQB.1991.056.01.010"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.12.1501"},{"key":"e_1_2_7_4_2","first-page":"71","article-title":"CDK6 (PLSTIRE) and CDK4 (PSK\u2010J3) are a distinct subset of the cyclin\u2010dependent kinases that associate with cyclin D1","volume":"9","author":"Bates S","year":"1994","journal-title":"Oncogene"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2004.02.005"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.2004-0959"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208618"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.20613"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.15.7634"},{"key":"e_1_2_7_10_2","first-page":"467","article-title":"Cyclin D1 overexpression in mouse epidermis increases cyclin\u2010dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development","volume":"10","author":"Rodriguez\u2010Puebla ML","year":"1999","journal-title":"Cell Growth Differ"},{"key":"e_1_2_7_11_2","first-page":"1641","article-title":"Enhanced skin carcinogenesis in cyclin D1\u2010conditional transgenic mice: Cyclin D1 alters keratinocyte response to calcium\u2010induced terminal differentiation","volume":"62","author":"Yamamoto H","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.16.2469"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.19.5310"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.20.2.672-683.2000"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/35082500"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209371"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1747-1028-1-15"},{"key":"e_1_2_7_18_2","first-page":"1005","article-title":"Alternate splicing produces a novel cyclin D1 transcript","volume":"11","author":"Betticher DC","year":"1995","journal-title":"Oncogene"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208326"},{"key":"e_1_2_7_20_2","first-page":"4903","article-title":"Specificity of cyclin D1 for androgen receptor regulation","volume":"63","author":"Petre\u2010Draviam CE","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M303969200"},{"key":"e_1_2_7_22_2","first-page":"7056","article-title":"An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene","volume":"63","author":"Lu F","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_7_23_2","first-page":"249","article-title":"Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer","volume":"60","author":"Kong S","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63038-6"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.2.257"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cccn.2003.12.010"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506281103"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209147"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-0436.1994.5810053.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3455"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/16.4.781"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64616-0"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1054\/npep.2002.0905"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90034-9"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61703-8"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.4.1881"},{"key":"e_1_2_7_37_2","first-page":"467","article-title":"Cyclin D1 overexpression in mouse epidermis increases cyclin\u2010dependent kinase activity and cell proliferation in vivo but does not affect skin tumor development","volume":"10","author":"Rodriguez\u2010Puebla ML","year":"1999","journal-title":"Cell Growth Differ"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210738"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206868"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209644"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-039859"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1586007"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200937"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.3.712"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-1772"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/369669a0"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(02)01055-7"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00570-1"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E04-08-0654"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.22.3488"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5382"}],"container-title":["Molecular Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmc.20489","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mc.20489","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T22:48:18Z","timestamp":1700002098000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mc.20489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,21]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1002\/mc.20489"],"URL":"https:\/\/doi.org\/10.1002\/mc.20489","archive":["Portico"],"relation":{},"ISSN":["0899-1987","1098-2744"],"issn-type":[{"value":"0899-1987","type":"print"},{"value":"1098-2744","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,21]]}}}